BioMediCan

BioMediCan is a biotechnology company based in Berkeley, California, focusing on research and development in synthetic biology and cellular agriculture. The company aims to commercialize its innovative intellectual property by developing organic, non-GMO rare cannabinoids through yeast fermentation, which allows for the efficient production of pharmaceutical-grade compounds. This approach offers a cost-effective alternative to conventional methods, enabling advancements in emerging industries. BioMediCan has assembled a team of global experts to expedite its research efforts and ensure the success of its initiatives.

Dennis O'Neill

Chief Investment Officer

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.